Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose

被引:102
作者
Abdul-Ghani, Muhammad A.
Williams, Ken
DeFronzo, Ralph
Stern, Michael
机构
[1] Univ Texas, Hlth Sci Ctr, Diabet Div, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Clin Epidemiol Unit, San Antonio, TX 78229 USA
关键词
D O I
10.2337/dc05-1711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - We sought to assess the risk of progression to type 2 diabetes in normal glucose tolerance (NGT) subjects based on the relationship between the plasma glucose concentration during oral glucose tolerance tests (OGTTs) and the fasting plasma glucose (FPG) concentration. RESEARCH DESIGN AND METHODS - Subjects with NGT (n = 1,282) from the San Antonio Heart Study received an OGTT with measurement of the plasma glucose concentration at 0, 30, 60, and 120 min at baseline and after 7-8 years of follow-up. Subjects were divided into four groups based on the relationship between the plasma glucose concentration during the OGTT and the FPG concentration on the same day as the OGTT. Insulin resistance was calculated by the homeostasis model assessment of insulin resistance (HOMA-IR) and Matsuda index. Early-phase insulin secretion was calculated as the ratio between the incremental plasma insulin and Glucose concentrations during the first 30 min of the OGTT (Delta I0-30/Delta G(0-30)). Total insulin secretion was calculated as the ratio between the incremental areas under the insulin and glucose curves during the OGTT [Delta G(AUC)/Delta I(AUC)]. RESULTS - In 23 subjects (group I), the plasma glucose concentration during the OGTT returned to levels below the FPG concentration at 30 min; in 111 subjects (group II) and in 313 subjects (group III), the plasma glucose concentration during the OGTT returned to levels below the FPG concentration at 60 and 120 min, respectively. In the remaining 835 subjects (group IV), the plasma Glucose concentration during the OGTT never fell below the FPG concentration. Insulin resistance, measured by HOMA-IR and the Matsuda index, increased progressively from group I through group IV, while insulin secretion measured by Delta I0-30/Delta G(0-30) and Delta G(AUC)/Delta I(AUC) decreased progressively from group I through group IV. The incidence of type 2 diabetes was 0% in group I and progressively increased to 0.9% in group II, 3.2% in Group III, and 6.4% in group IV. CONCLUSIONS - Subjects whose postload plasma glucose concentration returned to baseline (i.e., FPG level) more quickly had greater insulin sensitivity, a higher insulinogenic index, and a lower risk of developing type 2 diabetes after 8 years of follow-up compared with subjects whose postload glucose concentration returned to baseline more slowly.
引用
收藏
页码:1613 / 1618
页数:6
相关论文
共 30 条
[1]   The evolution of β-cell dysfunction and insulin resistance in type 2 diabetes [J].
Bergman, RN ;
Finegood, DT ;
Kahn, SE .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :35-45
[2]   Reduced early insulin secretion in the etiology of type 2 diabetes mellitus in Pima Indians [J].
Bogardus, C ;
Tataranni, PA .
DIABETES, 2002, 51 :S262-S264
[3]   Rapid rise in the incidence of type 2 diabetes from 1987 to 1996 - Results from the San Antonio Heart Study [J].
Burke, JP ;
Williams, K ;
Gaskill, SP ;
Hazuda, HP ;
Haffner, SM ;
Stern, MP .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (13) :1450-1456
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance - Poor agreement in the Hoorn study [J].
De Vegt, F ;
Dekker, JM ;
Stehouwer, CDA ;
Nijpels, G ;
Bouter, LM ;
Heine, R .
DIABETES CARE, 1998, 21 (10) :1686-1690
[6]   Pathogenesis of type 2 diabetes mellitus [J].
DeFronzo, RA .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (04) :787-+
[7]   THE TRIUMVIRATE - BETA-CELL, MUSCLE, LIVER - A COLLUSION RESPONSIBLE FOR NIDDM [J].
DEFRONZO, RA .
DIABETES, 1988, 37 (06) :667-687
[8]   Reproducibility of the diagnosis of diabetes over a 30-month follow-up -: The Paris Prospective Study [J].
Eschwège, E ;
Charles, MA ;
Simon, D ;
Thibult, N ;
Balkau, B .
DIABETES CARE, 2001, 24 (11) :1941-1944
[9]   β-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes:: A new analysis [J].
Ferrannini, E ;
Gastaldelli, A ;
Miyazaki, Y ;
Matsuda, M ;
Mari, A ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :493-500
[10]   Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance [J].
Ferrannini, E ;
Gastaldelli, A ;
Miyazaki, Y ;
Matsuda, M ;
Pettiti, M ;
Natali, A ;
Mari, A ;
DeFronzo, RA .
DIABETOLOGIA, 2003, 46 (09) :1211-1219